Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination

Nature Communications

Volumn 7, Issue , 2016, Pages

  Le, Caroline P ^a   Nowell, Cameron J ^a   Kim Fuchs, Corina ^a,b   Botteri, Edoardo ^c   Hiller, Jonathan G ^d   Ismail, Hilmy ^d   Pimentel, Matthew A ^a   Chai, Ming G ^a   Karnezis, Tara ^d,e   Rotmensz, Nicole ^c   Renne, Giuseppe ^c   Gandini, Sara ^c   Pouton, Colin W ^a   Ferrari, Davide ^e   Möller, Andreas ^f   Stacker, Steven A ^d,e   Sloan, Erica K ^a,d,g,h  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF BERN   (Switzerland)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYCLOOXYGENASE 2; VASCULOTROPIN C; VASCULAR ENDOTHELIAL GROWTH FACTOR C, MOUSE;

CANCER; CELLS AND CELL COMPONENTS; DISEASE CONTROL; NERVOUS SYSTEM; NUMERICAL MODEL; RODENT; TUMOR; WOMENS HEALTH;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; IN VIVO STUDY; INFLAMMATION; LYMPH FLOW; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHATIC VASCULATURE; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR CELL; TUMOR VASCULARIZATION; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; CELL LINE; CHRONIC DISEASE; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; LYMPHATIC SYSTEM; METABOLISM; NEOPLASM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; BREAST NEOPLASMS; CELL LINE; CHRONIC DISEASE; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC SYSTEM; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84959505908     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10634     Document Type: Article

References (70)

1. Elenkov, I. J., Wilder, R. L., Chrousos, G. P. & Vizi, E. S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52, 595-638 (2000).
2. McEwen, B. S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 87, 873-904 (2007).
3. Thaker, P. H. et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 12, 939-944 (2006).
4. Kim-Fuchs, C. et al. Chronic stress accelerates pancreatic cancer growth and invasion: a critical role for beta-adrenergic signaling in the pancreatic microenvironment. Brain Behav. Immun. 40, 40-47 (2014).
5. Magnon, C. et al. Autonomic nerve development contributes to prostate cancer progression. Science 341, 1236361 (2013).
6. Sloan, E. K. et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 70, 7042-7052 (2010).
7. Andersen, B. L. et al. Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer 113, 3450-3458 (2008).
8. Chida, Y., Hamer, M., Wardle, J. & Steptoe, A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat. Clin. Pract. Oncol. 5, 466-475 (2008).
9. He, Y. L. et al. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res. 65, 4739-4746 (2005).
10. Alitalo, A. & Detmar, M. Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene 31, 4499-4508 (2012).
11. Hayashi, K. et al. Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels. Cancer Res. 67, 8223-8228 (2007).
12. Swartz, M. A. The physiology of the lymphatic system. Adv. Drug Deliv. Rev. 50, 3-20 (2001).
13. Hons, M. & Sixt, M. The lymph node filter revealed. Nat. Immunol. 16, 338-340 (2015).
14. Bellingan, G. J., Caldwell, H., Howie, S. E., Dransfield, I. & Haslett, C. In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J. Immunol. 157, 2577-2585 (1996).
15. Stacker, S. A. et al. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat. Rev. Cancer 14, 159-172 (2014).
16. Cochran, A. J. et al. Tumour-induced immune modulation of sentinel lymph nodes. Nat. Rev. Immunol. 6, 659-670 (2006).
17. Fisher, B. & Fisher, E. R. Studies concerning the regional lymph node in cancer. I. Initiation of immunity. Cancer 27, 1001-1004 (1971).
18. Cohen, J. N. et al. Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation. J. Exp. Med. 207, 681-688 (2010).
19. Fisher, B. et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N. Engl. J. Med. 347, 1233-1241 (2002).
20. Arnaout-Alkarain, A., Kahn, H. J., Narod, S. A., Sun, P. A. & Marks, A. N. Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer. Mod. Pathol. 20, 183-191 (2007).
21. Nakamura, Y. et al. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Breast Cancer Res. Treat. 91, 125-132 (2005).
22. Felten, D. L. & Felten, S. Y. Sympathetic noradrenergic innervation of immune organs. Brain Behav. Immun. 2, 293-300 (1988).
23. Allen, J. M., McHale, N. G. & Rooney, B. M. Effect of norepinephrine on contractility of isolated mesenteric lymphatics. Am. J. Physiol. 244, H479-H486 (1983).
24. McGeown, J. G., McHale, N. G. & Thornbury, K. D. The effect of electrical stimulation of the sympathetic chain on peripheral lymph flow in the anaesthetized sheep. J. Physiol. 393, 123-133 (1987).
25. McHale, N. G. & Thornbury, K. D. Sympathetic stimulation causes increased output of lymphocytes from the popliteal node in anaesthetized sheep. Exp. Physiol. 75, 847-850 (1990).
26. Lamkin, D. M. et al. Chronic stress enhances progression of acute lymphoblastic leukemia via beta-adrenergic signaling. Brain Behav. Immun. 26, 635-641 (2012).
27. Banerji, S. et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144, 789-801 (1999).
28. Karnezis, T. et al. VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell 21, 181-195 (2012).
29. Rak, J. VEGF-d(ilated) lymphatics as gateways to metastasis. Cancer Cell 21, 139-140 (2012).
30. Tsopelas, C. & Sutton, R. Why certain dyes are useful for localizing the sentinel lymph node. J. Nucl. Med. 43, 1377-1382 (2002).
31. Sleeman, J. P. & Thiele, W. Tumor metastasis and the lymphatic vasculature. Int. J. Cancer 125, 2747-2756 (2009).
32. Padera, T. P. et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296, 1883-1886 (2002).
33. Eckhardt, B. L. et al. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. Mol. Cancer Res. 3, 1-13 (2005).
34. Wong, C. S. et al. Vascular normalization by loss of Siah2 results in increased chemotherapeutic efficacy. Cancer Res. 72, 1694-1704 (2012).
35. Taniguchi, M., Kasaba, T. & Takasaki, M. Epidural anesthesia enhances sympathetic nerve activity in the unanesthetized segments in cats. Anesth. Analg. 84, 391-397 (1997).
36. Dixon, J. B. et al. Lymph flow, shear stress, and lymphocyte velocity in rat mesenteric prenodal lymphatics. Microcirculation 13, 597-610 (2006).
37. Daly, C. J. & McGrath, J. C. Previously unsuspected widespread cellular and tissue distribution of beta-adrenoceptors and its relevance to drug action. Trends Pharmacol. Sci. 32, 219-226 (2011).
38. Liu, D. et al. β2-AR signaling controls trastuzumab resistance-dependent pathway. Oncogene 35, 47-58 (2015).
39. Armaiz-Pena, G. N. et al. Src activation by beta-adrenoreceptors is a key switch for tumour metastasis. Nat. Commun. 4, 1403 (2013).
40. Kinoshita, J. et al. Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer. Breast Cancer Res. Treat. 66, 159-164 (2001).
41. Li, L. et al. Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer. Anticancer Res. 24, 1973-1979 (2004).
42. Nakamura, Y. et al. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up. Clin. Cancer Res. 9, 716-721 (2003).
43. Skobe, M. et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 7, 192-198 (2001).
44. Mandriota, S. J. et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 20, 672-682 (2001).
45. Jeltsch, M. et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276, 1423-1425 (1997).
46. Makinen, T. et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20, 4762-4773 (2001).
47. Su, J. L. et al. The role of the VEGF-C/VEGFR-3 axis in cancer progression. Br. J. Cancer 96, 541-545 (2007).
48. Liggett, S. B. Beta-adrenoceptor-effector system of the human macrophage U937 cell line. Eur. J. Pharmacol. 163, 171-174 (1989).
49. Kyzas, P. A., Stefanou, D. & Agnantis, N. J. COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma. Mod. Pathol. 18, 153-160 (2005).
50. von Rahden, B. H. et al. Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma. Cancer Res. 65, 5038-5044 (2005).
51. Zhang, X. H. et al. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer. BMC Cancer 8, 4 (2008).
52. Timoshenko, A. V., Chakraborty, C., Wagner, G. F. & Lala, P. K. COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer. Br. J. Cancer 94, 1154-1163 (2006).
53. Shaw, J. O., Russell, S. W., Printz, M. P. & Skidgel, R. A. Macrophage-mediated tumor cell killing: lack of dependence on the cyclooxygenase pathway of prostaglandin synthesis. J. Immunol. 123, 50-54 (1979).
54. Mantovani, A., Sozzani, S., Locati, M., Allavena, P. & Sica, A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555 (2002).
55. Powell, N. D. et al. Social stress up-regulates inflammatory gene expression in the leukocyte transcriptome via beta-adrenergic induction of myelopoiesis. Proc. Natl Acad. Sci. USA 110, 16574-16579 (2013).
56. Hla, T. & Neilson, K. Human cyclooxygenase-2 cDNA. Proc. Natl Acad. Sci. USA 89, 7384-7388 (1992).
57. Barron, T. I., Connolly, R. M., Sharp, L., Bennett, K. & Visvanathan, K. Beta blockers and breast cancer mortality: a population-based study. J. Clin. Oncol. 29, 2635-2644 (2011).
58. Powe, D. G. et al. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget 1, 628-638 (2010).
59. Melhem-Bertrandt, A. et al. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J. Clin. Oncol. 29, 2645-2652 (2011).
60. Botteri, E. et al. Therapeutic effect of beta-blockers in triple-negative breast cancer postmenopausal women. Breast Cancer Res. Treat. 140, 567-575 (2013).
61. Wong, S. Y. & Hynes, R. O. Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle 5, 812-817 (2006).
62. Lund, A. W. et al. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Rep. 1, 191-199 (2012).
63. Allen, J. M., McCarron, J. G., McHale, N. G. & Thornbury, K. D. Betaadrenoceptor-mediated facilitation of [3H]-noradrenaline release from the intramural nerves of bovine mesenteric lymphatic vessels. Br. J. Pharmacol. 96, 45-50 (1989).
64. Hiller, J. G., Hacking, M. B., Link, E. K., Wessels, K. L. & Riedel, B. J. Perioperative epidural analgesia reduces cancer recurrence after gastrooesophageal surgery. Acta. Anaesthesiol. Scand. 58, 281-290 (2014).
65. Kaminskas, L. M. et al. PEGylation of interferon alpha2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases. J. Control. Release 168, 200-208 (2013).
66. Sundstrom, C. & Nilsson, K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17, 565-577 (1976).
67. Magnusdottir, H., Kirno, K., Ricksten, S. E. & Elam, M. High thoracic epidural anesthesia does not inhibit sympathetic nerve activity in the lower extremities. Anesthesiology 91, 1299-1304 (1999).
68. Ferrari, S. L. P. & Cribari-Neto, F. Beta regression for modelling rates and proportions. J. Appl. Stat. 31, 799-815 (2004).
69. Gray, R. J. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann. Stat. 16, 1141-1154 (1988).
70. R Development Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2011).